Altered gut microbiome function in ADHD: More Prevotella, less vitamin B12 biosynthesis, and beneficial modulation by

Miranda Stiernborg1, Liu L Yang2, Elin Skott3

  • 1Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden; Center for Molecular Medicine, Karolinska University Hospital Solna, Stockholm, Sweden.

PubMed

Insights

This study reveals distinct gut microbiome differences in adults with ADHD. Synbiotic 2000 modulated the gut microbiome and increased short-chain fatty acids (SCFAs) in ADHD patients.

Area of Science:

  • Microbiome research
  • Neuroscience
  • Gastroenterology

Background:

  • The gut microbiome's role in Attention Deficit Hyperactivity Disorder (ADHD) is largely unknown.
  • Psychostimulant medications are common ADHD treatments, but their gut microbiome effects are unexplored.
  • Synbiotic 2000, a probiotic and prebiotic, shows promise for ADHD symptom reduction.

Purpose of the Study:

  • To characterize the fecal bacterial microbiome in ADHD patients compared to controls.
  • To investigate the impact of Synbiotic 2000 on the gut microbiome in ADHD.
  • To explore associations between psychostimulants, gut microbiome composition, and host factors.

Main Methods:

  • Shallow shotgun sequencing of fecal samples from 147 ADHD participants and 106 completers.
  • Machine learning analysis for microbiome diversity and differential abundance.
  • Measurement of plasma short-chain fatty acids (SCFAs) and serum vitamin B12.

Main Results:

  • Adult ADHD patients showed altered abundances of four bacterial species compared to controls.
  • Children on psychostimulants had increased Prevotella and decreased vitamin B12 synthesis modules (M00122).
  • Synbiotic 2000 altered microbiome diversity and increased plasma SCFA levels (formic and propionic acids).

Conclusions:

  • Distinct gut bacterial species are associated with ADHD in adults.
  • Psychostimulant use in children with ADHD correlates with specific microbiome and metabolic alterations.
  • Synbiotic 2000 demonstrates potential for modulating the gut microbiome and SCFA levels in ADHD treatment.

Related Concept Videos

Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
736
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
631
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
618
Irritable Bowel Syndrome I: Introduction01:17

Irritable Bowel Syndrome I: Introduction

Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
910
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
743
Physiology of Enteric Nervous System and Gut Health01:05

Physiology of Enteric Nervous System and Gut Health

The gastrointestinal tract, responsible for the digestion and absorption of nutrients, is safeguarded by the intestinal barrier, which consists of secretory, physical, and immune components. At the forefront is the secretory barrier, composed of essential elements such as mucus, gut microbiota, and defense proteins. They collaborate to break down food particles, facilitate nutrient absorption, and maintain optimal gut health. These secretory components ensure the smooth functioning of the...
856